Alliance Pharma PLC (LSE:APH) - Share price - Overview

Stock Report

Alliance Pharma PLC APH

Last Price
GBX58.00

Day Change
0.00|0.00%

As of 17/11/2017
16:55:59 GMT | GBX
Minimum 15 Minutes Delay.

Last Close58.00p
Day Range58.00 - 60.25
Mkt Cap275.10Mil
52-Wk Range41.79 - 62.75
Yield %1.90
ISINGB0031030819
Volume196,749
P/E15.18
P/S2.79
P/CF18.76

Share Price

Total Returns 17/11/2017

 Chg (%)  
More ...
Alliance Pharma PLC-0.43 
FTSE 100 TR GBP-1.44
 
Financials
201420152016
More ...
Income Statement
Turnover43.5448.3497.49
Operating Profit11.1716.9625.61
Net Profit8.3912.6918.09
Reported EPS3.164.553.82
Balance Sheet
Current Assets15.6727.7749.28
Non Current Assets92.20264.43271.45
Total Assets107.87292.19320.74
Current Liabilities11.4231.7650.28
Total Liabilities37.09129.75141.47
Total Equity70.78162.44179.26
Cash Flow
Operating Cash Flow13.459.8419.96
Net Change in Cash2.432.093.43
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
201724.773.891.8314.918.141.322.28
201826.804.3511.7213.351.141.472.54
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
14/02/2017Sale of Option SharesMr. Peter Butterfield48.7561,84630,150.00
14/02/2017Exercise of OptionMr. Peter Butterfield33.2590,22229,999.00

Company Profile

Alliance Pharma PLC is a pharmaceutical products manufacturer. It distributes its products through wholesalers, retail pharmacies, hospitals and an international network of distributors.

Sector

Drug Manufacturers - Specialty & Generic

Market Position

622 of 1833 Companies

Index

FTSE AIM 100 ,FTSE AIM All Share

Outlook

(13/09/2017) "...we look forward to the second half and beyond with confidence"

Next Event 21/12/2017

Ex Dividend
Ratios
CompSecMkt
More ...
PER (E)13.5213.6316.14
Div Yld (E)2.514.134.26
PEG (E)1.281.241.34
ROCE90.43180.3415.81
Op Mrgn26.67-8.42-9.53
EPS Grwth10.5512.8214.73
Dividends
PreviousLatest
More ...
Record Date16/06/1722/12/17
Ex-Div15/06/1721/12/17
Paid12/07/1711/01/18
Amnt0.810.44

Broker Sentiment

Strong Buy0
Buy3
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Andrew Smith
Chief Executive OfficerMr. John Dawson
Finance DirectorAndrew Franklin
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.